Search Results 901-910 of 7657 for Subacute

1. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   The phase 1 primary objectives of this study are to assess the safety profile, characterize pharmacokinetics (PK) and determine the dosing schedule, maximum ...

2. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

3. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

4. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

5. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

6. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

7. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

8. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

9. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   This study will also evaluate other anti-tumor effects, tumor markers and pharmacokinetics (PK) of zolbetuximab, Nab-P and GEM. Participation eligibility.

10. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.